I work to apply genomic and computational technologies to improve human health with a primary emphasis on improving outcomes for people with cancer. The work in our lab works at all phases from technology/method development, to application of technologies to answer critical questions in cancer biology, to population studies to understand the impact of genetic variation of disease, and to implementation trials that directly impact health. Current funded research focuses on systematic analysis of genetic and gene regulation information in clinical cohorts as part of the Genome Data Analysis Network and a clinical trial implementing genetic health screening for hereditary breast and ovarian cancer and Lynch syndromes. Other areas of interest include polygenic risk implementation and modeling, precision medicine, and understanding the molecular biology of cellular replication.